Moneycontrol Be a Pro
Get App
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Norris Medicine
Norris Medicine
BSE: 524414NSE: ISIN: INE744C01029

29th-Jul-2019 11:12Source: BSE

Norris Medicines - Board Meeting Intimation for Consideration Of Unaudited Financial Results Of The Quarter Ended On 30Th June, 2019

NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2019.

Follow us on
Available On
PCI DSS Compliant